Table 2.
Control (n = 83,302) | HP-infected group (n = 41,651) | |
---|---|---|
Follow-up person-months | 8,323,634 | 4,275,515 |
New SLE case | 60 | 50 |
Incidence rate* (95% CI) | 0.72 (0.56–0.93) | 1.17 (0.89–1.54) |
Crude relative risk (95% CI) | Reference | 1.63 (1.12–2.37) |
Incidence rate per 100,000 person-months.